References
Delanty N, French J. Treatment of Lennox-Gastaut syndrome: current recommendations. CNS Drugs 1998 Sep; 10(3): 181–8
Felbamate Study Group in Lennox-Gastaut Syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993; 328: 29–33
Motte J, Trevathan E, Arvidsson JFV, et al. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. N Engl J Med 1997; 337: 1807–12
Dodson WE. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial. Epilepsia 1993; 34 Suppl. 7: S18–24
van Engelen BGM, Renier WO, Weemaes CMR, et al. High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox-Gastaut syndrome: an add-on study. Eur J Pediatr 1994; 153: 762–9
Kinsman SL, Vining EP, Quaskey SA, et al. Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 1992; 33: 1132–6
Hornig GW, Murphy JV, Schallert G, et al. Left vagus nerve stimulation in children with refractory epilepsy. South Med J 1997; 90: 484–8
Lamotrigine for adults and children. Prescrire International 1999 June; 8(41): 80–2
Bryant AE, Dreifuss FE. Valproic acid hepatic fatalities: III. U.S. experience since 1986. Neurology 1996; 46: 465–9
Dimario FJ, Clancy RR. Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures. Pediatr Neurol 1988; 4: 249–51
Rights and permissions
About this article
Cite this article
No optimal treatment yet for patients with Lennox-Gastaut syndrome. Drugs Ther. Perspect 14, 10–12 (1999). https://doi.org/10.2165/00042310-199914050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199914050-00004